首页> 外文期刊>BMC Cardiovascular Disorders >Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study
【24h】

Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study

机译:髓样细胞-1上表达的可溶性触发受体在心脏手术后诊断呼吸机相关性肺炎中的作用:一项观察性研究

获取原文
           

摘要

Background The diagnosis of ventilator-associated pneumonia (VAP) is a challenge, particularly after cardiac surgery. The use of biological markers of infection has been suggested to improve the accuracy of VAP diagnosis. We aimed to evaluate the usefulness of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in the diagnosis of VAP following cardiac surgery. Methods This was a prospective observational cohort study of children with congenital heart disease admitted to the pediatric intensive care unit (PICU) after surgery and who remained intubated and mechanically ventilated for at least 24?hours postoperatively. VAP was defined by the 2007 Centers for Disease Control and Prevention criteria. Blood, modified bronchoalveolar lavage (mBAL) fluid and exhaled ventilator condensate (EVC) were collected daily, starting immediately after surgery until the fifth postoperative day or until extubation for measurement of sTREM-1. Results Thirty patients were included, 16 with VAP. Demographic variables, Pediatric Risk of Mortality (PRISM) and Risk Adjustment for Congenital Heart Surgery (RACHS)-1 scores, duration of surgery and length of cardiopulmonary bypass were not significantly diferent in patients with and without VAP. However, time on mechanical ventilation and length of stay in the PICU and in the hospital were significantly longer in the VAP group. Serum and mBAL fluid sTREM-1 concentrations were similar in both groups. In the VAP group, 12 of 16 patients had sTREM-1 detected in EVC, whereas it was undetectable in all but two patients in the non-VAP group over the study period (p?=?0.0013) (sensitivity 0.75, specificity 0.86, positive predictive value 0.86, negative predictive value 0.75, positive likelihood ratio (LR) 5.25, negative LR 0.29). Conclusion Measurement of sTREM-1 in EVC may be useful for the diagnosis of VAP after cardiac surgery.
机译:背景技术呼吸机相关性肺炎(VAP)的诊断是一项挑战,特别是在心脏手术后。已建议使用感染的生物标志物来提高VAP诊断的准确性。我们旨在评估髓样细胞(sTREM)-1上表达的可溶性触发受体在心脏手术后VAP诊断中的实用性。方法这是一项前瞻性观察性队列研究,研究对象为先天性心脏病患儿在手术后入院并在术后至少24小时保持插管和机械通气的情况。 VAP由2007年疾病控制和预防中心标准定义。每天收集血液,改良的支气管肺泡灌洗液(mBAL)和呼出的呼吸机冷凝物(EVC),从手术后立即开始直到术后第五天或直到拔管以测量sTREM-1。结果纳入30例患者,其中VAP 16例。在有和没有VAP的患者中,人口统计学变量,儿童死亡风险(PRISM)和先天性心脏手术风险调整(RACHS)-1得分,手术时间和体外循环时间没有显着不同。但是,VAP组的机械通气时间和在PICU和医院的住院时间明显更长。两组的血清和mBAL液sTREM-1浓度相似。在VAP组中,在研究期间16例患者中有12例在EVC中检测到sTREM-1,而在非VAP组中,除2例患者以外,其他所有患者均未检测到sTREM-1(p?= 0.0013)(敏感性0.75,特异性0.86,正预测值0.86,负预测值0.75,正似然比(LR)5.25,负LR 0.29)。结论EVC中sTREM-1的测定可能对心脏手术后VAP的诊断有帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号